Congenital Heart Surgery Nomenclature and Database Project: diseases of the pericardium

S M Mehta1, J L Myers

  • 1Pediatric Cardiovascular Surgery, Children's Hospital, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033, USA.

Insights

This study reviews pericardial disease nomenclature to create a unified reporting system. A comprehensive database framework is proposed for improved data sharing and risk stratification in cardiac surgery.

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Medical Informatics

Background:

  • Existing nomenclature for pericardial diseases lacks standardization.
  • This variability hinders consistent data collection and analysis.

Purpose of the Study:

  • To review and unify the nomenclature for pericardial diseases.
  • To establish a standardized reporting system for pericardial conditions.
  • To facilitate data sharing and risk stratification in cardiac surgery.

Main Methods:

  • A review of existing pericardial disease nomenclature was conducted.
  • Discussions involved members of the STS-Congenital Heart Surgery Database Committee and the European Association for Cardiothoracic Surgery.
  • A hierarchical database scheme was developed, including a minimum dataset.

Main Results:

  • A comprehensive list of pericardial disease categories was identified, including effusive pericarditis, constrictive pericarditis, cardiac tamponade, and postoperative complications.
  • A hierarchical database structure was proposed for data entry at varying levels of detail.
  • A minimum database set was defined for basic trend interpretation and data sharing.

Conclusions:

  • A unified nomenclature and database system for pericardial diseases is essential for standardized reporting.
  • The proposed system supports comprehensive risk stratification and facilitates data sharing among institutions.
  • This framework will improve the understanding and management of pericardial conditions in clinical practice.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...